Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S2, 2019. DOI: 10.25251/skin.3.supp.2. Disponível em: https://skin.dermsquared.com/skin/article/view/729. Acesso em: 19 apr. 2025.